1 research outputs found
ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° Π½Π° ΡΠ°Π½Π½Π΅Π΅ ΠΏΠΎΡΡΠ½Π°ΡΠΊΠΎΠ·Π½ΠΎΠ΅ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
Objective: to evaluate the effect of the metabolic antihypoxant cytoflavin on the course of early postanesthetic recovery in patients operated on for various cancers. Subjects and methods: Fifty-seven patients aged 30 to 65 years, operated on for gynecological cancer, were examined. The patients were divided into 2 groups: 1) 28 patients who took cytoflavin and 2) 29 who did not. At the end of an operation, the agent was intravenously injected in a dose of 10 ml in a mixture with an equal volume of 0.9% sodium chloride solution. Thiopental sodium was used for initial anesthesia; arduan was employed to maintain muscle relaxation. Neuroleptic analgesia with fentanyl and droperidol or ataralgesia (fentanyl + relanium) was applied in both groups. The levels of hemoglobin, glucose, sodium, potassium, calcium, malonic dialdehyde (MDA) (Andreyev’s test), antioxidative activity (AOA) (Semenov’s test) were measured to evaluate the functional state of patients. The rating system for determining the recovery of consciousness, respiration, and motor activity, proposed by Aldret and Kroulik [8], and Bidway’s psychological testing, blood oxygen saturation and cardiac performance monitoring (TRITON, Russia) and some others were used to evaluate the efficacy of the drug in the early postanesthetic period. The results were statistically processed using Microsoft Excel and a package of Biostatistics 6.0. Results. The use of cytoflavin at the end of surgery has been established to have a beneficial effect on the early recovery period. This is manifested as shorter recovery of consciousness and respiration mainly in the ataralgesia group; fair oxygen saturation, lower MDA concentrations and higher AOA are revealed. Conclusion. Cytoflavin significantly reduces the recovery of consciousness and adequate respiration and the incidence of the fever, muscle tremor syndrome and fails to favor the occurrence of hypoglycemia. Inclusion of cytoflavin into a complex of anesthetic measures ensures metabolic correction, by enhancing the antioxidative activity of plasma and lowering the concentration of incomplete oxidation products (MDA). Key words: cytoflavin, succinic acid, gynecological cancer, early postanesthetic recovery.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΡΠ΅Π½ΠΈΡΡ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½ΡΠΈΠ³ΠΈΠΏΠΎΠΊΡΠ°Π½ΡΠ° ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° Π½Π° ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ°Π½Π½Π΅Π³ΠΎ ΠΏΠΎΡΡΠ½Π°ΡΠΊΠΎΠ·Π½ΠΎΠ³ΠΎ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
, ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΡ
Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π° ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Ρ Ρ 57-ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 30 Π΄ΠΎ 65 Π»Π΅Ρ, ΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΠΎΠ½ΠΊΠΎΠ³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. ΠΠ°ΡΠΈΠ΅Π½ΡΡ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° 2 Π³ΡΡΠΏΠΏΡ: 1-Ρ Π³ΡΡΠΏΠΏΠ° β Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° β 28 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ, 2-Ρ Π³ΡΡΠΏΠΏΠ° β Π±Π΅Π· ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° β 29 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ. ΠΡΠ΅ΠΏΠ°ΡΠ°Ρ Π²Π²ΠΎΠ΄ΠΈΠ»ΠΈ Π² ΠΊΠΎΠ½ΡΠ΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π²/Π² Π² Π΄ΠΎΠ·Π΅ 10,0 ΠΌΠ» Π² ΡΠΌΠ΅ΡΠΈ Ρ ΡΠ°Π²Π½ΡΠΌ ΠΎΠ±ΡΠ΅ΠΌΠΎΠΌ 0,9% ΡΠ°ΡΡΠ²ΠΎΡΠ° Ρ
Π»ΠΎΡΠΈΠ΄Π° Π½Π°ΡΡΠΈΡ. ΠΠ»Ρ Π²Π²ΠΎΠ΄Π½ΠΎΠ³ΠΎ Π½Π°ΡΠΊΠΎΠ·Π° ΠΏΡΠΈΠΌΠ΅Π½ΡΠ»ΠΈ ΡΠΈΠΎΠΏΠ΅Π½ΡΠ°Π» Π½Π°ΡΡΠΈΡ, Ρ ΡΠ΅Π»ΡΡ ΠΏΠΎΠ΄Π΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΠ΅Π»Π°ΠΊΡΠ°ΡΠΈΠΈ ΠΌΡΡΡ ΠΏΡΠΈΠΌΠ΅Π½ΡΠ»ΠΈ Π°ΡΠ΄ΡΠ°Π½. Π ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏΠΏΠ°Ρ
ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈΠΊΡ Π½Π΅ΠΉΡΠΎΠ»Π΅ΠΏΡΠΎΠ°Π½Π°Π»ΡΠ³Π΅Π·ΠΈΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌΠΈ ΡΠ΅Π½ΡΠ°Π½ΠΈΠ» ΠΈ Π΄ΡΠΎΠΏΠ΅ΡΠΈΠ΄ΠΎΠ», Π»ΠΈΠ±ΠΎ Π°ΡΠ°ΡΠ°Π»Π³Π΅Π·ΠΈΡ (ΡΠ΅Π½ΡΠ°Π½ΠΈΠ» + ΡΠ΅Π»Π°Π½ΠΈΡΠΌ). Π‘ ΡΠ΅Π»ΡΡ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π³Π΅ΠΌΠΎΠ³Π»ΠΎΠ±ΠΈΠ½Π°, Π³Π»ΡΠΊΠΎΠ·Ρ, Π½Π°ΡΡΠΈΡ, ΠΊΠ°Π»ΠΈΡ, ΠΊΠ°Π»ΡΡΠΈΡ, ΠΠΠ (ΠΌΠ°Π»ΠΎΠ½ΠΎΠ²ΡΠΉ Π΄ΠΈΠ°Π»ΡΠ΄Π΅Π³ΠΈΠ΄ -ΠΌΠ΅ΡΠΎΠ΄ ΠΠ½Π΄ΡΠ΅Π΅Π²Π°), Π°Π½ΡΠΈΠΎΠΊΠΈΡΠ»ΠΈΡΠ΅Π»ΡΠ½ΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ (ΠΠΠ) ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π‘Π΅ΠΌΠ΅Π½ΠΎΠ²Π° ΠΈ Π―ΡΠΎΡ). ΠΠ»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Π² ΡΠ°Π½Π½ΠΈΠΉ ΠΏΠΎΡΡΠ½Π°ΡΠΊΠΎΠ·Π½ΡΠΉ ΠΏΠ΅ΡΠΈΠΎΠ΄ Π±ΡΠ»Π° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½Π° ΡΠΈΡΡΠ΅ΠΌΠ° ΠΎΡΠ΅Π½ΠΊΠΈ ΡΡΠΎΠ²Π½Ρ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΡΠΎΠ·Π½Π°Π½ΠΈΡ, Π΄ΡΡ
Π°Π½ΠΈΡ ΠΈ Π΄Π²ΠΈΠ³Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΠΎ ΡΠΊΠ°Π»Π΅, ΠΏΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½ΠΎΠΉ Aldret ΠΈ Kroulik [8], ΠΈ ΠΏΡΠΈΡ
ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠΎ ΡΠ΅ΡΡΡ Bidway, ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³ ΡΠ°ΡΡΡΠ°ΡΠΈΠΈ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π° Π² ΠΊΡΠΎΠ²ΠΈ, ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΠΉ Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ (Π’Π ΠΠ’ΠΠ, Π ΠΎΡΡΠΈΡ) ΠΈ ΡΡΠ΄ Π΄ΡΡΠ³ΠΈΡ
. Π‘ΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΡΡ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΡ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Microsoft Excel ΠΈ ΠΏΠ°ΠΊΠ΅ΡΠ° ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌ Biostatistics 6.0. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° Π² ΠΊΠΎΠ½ΡΠ΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎ Π²Π»ΠΈΡΠ΅Ρ Π½Π° ΠΏΠ΅ΡΠΈΠΎΠ΄ ΡΠ°Π½Π½Π΅Π³ΠΎ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ. ΠΡΠΎ ΠΏΡΠΎΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠ΅ΠΌ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΡΠΎΠ·Π½Π°Π½ΠΈΡ, Π΄ΡΡ
Π°Π½ΠΈΡ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ Π² Π³ΡΡΠΏΠΏΠ΅ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π°ΡΠ°ΡΠ°Π»Π³Π΅Π·ΠΈΠΈ, Π²ΡΡΠ²Π»Π΅Π½Ρ ΡΠ΄ΠΎΠ²Π»Π΅ΡΠ²ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΠ°ΡΡΡΠ°ΡΠΈΠΈ ΠΊΠΈΡΠ»ΠΎΡΠΎΠ΄Π°, ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΠΠ ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΠΠΠ. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠΌΠ΅Π½ΡΡΠ°Π΅Ρ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΡΠΎΠ·Π½Π°Π½ΠΈΡ, Π°Π΄Π΅ΠΊΠ²Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ, ΡΠ½ΠΈΠΆΠ°Π΅Ρ ΡΠ°ΡΡΠΎΡΡ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ Π‘ΠΠΠ ΠΈ Π½Π΅ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΡΠ΅Ρ ΠΏΠΎΡΠ²Π»Π΅Π½ΠΈΡ Π³ΠΈΠΏΠΎΠ³Π»ΠΈΠΊΠ΅ΠΌΠΈΠΈ. ΠΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅ ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½Π° Π² ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡ Π°Π½Π΅ΡΡΠ΅Π·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΠΎΡΠΎΠ±ΠΈΡ ΠΎΠ±Π΅ΡΠΏΠ΅ΡΠΈΠ²Π°Π΅Ρ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΡΡ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ Π·Π° ΡΡΠ΅Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΡ Π°Π½ΡΠΈΠΎΠΊΠΈΡΠ»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΏΠ»Π°Π·ΠΌΡ ΠΈ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ² Π½Π΅ΠΏΠΎΠ»Π½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ (ΠΠΠ). ΠΠ»ΡΡΠ΅Π²ΡΠ΅ ΡΠ»ΠΎΠ²Π°: ΡΠΈΡΠΎΡΠ»Π°Π²ΠΈΠ½, ΡΠ½ΡΠ°ΡΠ½Π°Ρ ΠΊΠΈΡΠ»ΠΎΡΠ°, ΠΎΠ½ΠΊΠΎΠ³ΠΈΠ½Π΅ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ, ΡΠ°Π½Π½Π΅Π΅ ΠΏΠΎΡΡΠ½Π°ΡΠΊΠΎΠ·Π½ΠΎΠ΅ Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΠ΅